Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rizwan Romee

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Blood Advances|October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplantMary Nauffal, Haesook T Kim, Paul G Richardson, et al.
American Journal of Hematology|June 2, 2017
Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic stateArmin Rashidi, Alaa M Ali, Kiran R Vij, et al.
Experimental Hematology & Oncology|November 14, 2024
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunitiesKamlesh Bisht, Aimee Merino, Rob Igarashi, et al.
Transplantation and Cellular Therapy|September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center ExperienceKuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Transplantation and Cellular Therapy|May 4, 2024
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center AnalysisHaesook T Kim, Vincent T Ho, Sarah Nikiforow, et al.
Leukemia Research|October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDSEric Huselton, Michael P Rettig, Kirsten Campbell, et al.
Haematologica|April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantationHaesook T Kim, Robert J Soiffer, Corey Cutler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathwaysRyan P Sullivan, Leslie A Fogel, Jeffrey W Leong, et al.
Blood|October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myelomaJooeun Bae, Shuichi Kitayama, Zach Herbert, et al.
Haematologica|July 23, 2016
Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamideScott R Goldsmith, Michael Slade, John F DiPersio, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Blood Advances|October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplantMary Nauffal, Haesook T Kim, Paul G Richardson, et al.
American Journal of Hematology|June 2, 2017
Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic stateArmin Rashidi, Alaa M Ali, Kiran R Vij, et al.
Experimental Hematology & Oncology|November 14, 2024
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunitiesKamlesh Bisht, Aimee Merino, Rob Igarashi, et al.
Transplantation and Cellular Therapy|September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center ExperienceKuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Transplantation and Cellular Therapy|May 4, 2024
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center AnalysisHaesook T Kim, Vincent T Ho, Sarah Nikiforow, et al.
Leukemia Research|October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDSEric Huselton, Michael P Rettig, Kirsten Campbell, et al.
Haematologica|April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantationHaesook T Kim, Robert J Soiffer, Corey Cutler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathwaysRyan P Sullivan, Leslie A Fogel, Jeffrey W Leong, et al.
Blood|October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myelomaJooeun Bae, Shuichi Kitayama, Zach Herbert, et al.
Haematologica|July 23, 2016
Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamideScott R Goldsmith, Michael Slade, John F DiPersio, et al.
Pageof 15